We describe the design and rationale of the ODYSSEY DM-DYSLIPIDEMIA study that assesses the efficacy and safety of alirocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, versus lipid-lowering usual care in individuals with T2DM and mixed dyslipidaemia at high cardiovascular ...
风险被认为是实质上通过 dyslipidemia,高血压,胰岛素抵抗力, DM,煽动性的路调停。 翻译结果3复制译文编辑译文朗读译文返回顶部 风险被认为通过血脂异常、 高血压、 胰岛素抵抗、 DM、 炎症通路介导的极大地。 翻译结果4复制译文编辑译文朗读译文返回顶部 风险被认为由dyslipidemia、高血压、胰岛素抗性、DM和激动的路极大...
It occurs more frequently in women with prior GDM and in individuals with hypertension or dyslipidemia, and its frequency varies in different racial/ ethnic subgroups. It is often associated with a strong genetic predisposition, more so than is the autoimmune form of type 1 diabetes. However, ...
通过合理选择和联合使用降脂药物,结合生活方式干预,患者可以实现更好的血脂管理和心血管保护。 参考文献: AACE Clinical Guidance: American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia. Endocrine Practice, 2025....
Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia. However, in some patients who have diabetes, crystalline nicotinic acid decreases glycemic control; this effect could be due to a marked rebound of non... GL Vega,...
摘要: We are using targeted NGS to sequence known dyslipidemia genes and simultaneously polygenic contributors to plasma lipids in patients referred to a tertiary care lipid clinic. We are also studying…" [more]年份: 1993 收藏 引用 批量引用 报错 分享 全部来源 求助全文 ResearchGate ...
(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 inJAMA Cardiology. Ad Marshal B. Elam, M.D., Ph.D., from the Memphis Veterans Affairs Medical Center and University ...
1.II型糖尿病发病机制研究证据 对Pima印地安人2型糖尿病自然病史的 长期纵向随访研究发现：正常糖耐量（NGT）糖尿病前期(IGT)临床糖尿病期（DM）的过程中，包含了胰岛素分泌和胰岛素利用的双重缺陷。II型糖尿病发病机制研究证据 胰岛素对葡萄糖（GLU）刺激的快速释放障 碍（反映胰岛β细胞功能）以及胰岛素刺激的 GLU...
AD与DM TheRelationshipbetweenAlzheimer'sdisease(AD)andtype2diabetesmellitus(T2D)TheRelationshipbetweenAlzheimer'sdisease(AD)andtype2diabetesmellitus(T2D)1 clinic obsitymetabolicsyndromehyperinsulinemia 2 mechanism AGEoxidativestressinsulinresistance 3 treatment anti-diabetesAGE-inhibit...
Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia Koch TC, Briviba K et al (2008) Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather ... TCL...